Integrated Filing — IndAS


General information about company

Scrip Code 543298
NSE Symbol VINEETLAB
MSEI Symbol NOTLISTED
ISIN INE505Y01010
Name of company VINEET LABORATORIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 12-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Active pharmaceuticals ingredient and intermediates
Start date and time of board meeting 12-May-2025   15:30:00
End date and time of board meeting 12-May-2025   17:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-12
Indicate Company website link for updated RPT policy of the Company https://vineetlabs.co.in/images/pdf/policies-and-code-of-conduct/related-party-transactions-policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The Company has not defaulted on loans and no debt securities were issued.



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 140765000 749950000
Other income 13814000 19868000
Total income 154579000 769818000
2 Expenses
(a) Cost of materials consumed 127066000 637684000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 78634000 64700000
(d) Employee benefit expense 13508000 53358000
(e) Finance costs 8999000 39776000
(f) Depreciation, depletion and amortisation expense 6574000 25016000
(f) Other Expenses
1 other Expenses 32011000 157039000
Total other expenses 32011000 157039000
Total expenses 266792000 977573000
3 Total profit before exceptional items and tax -112213000 -207755000
4 Exceptional items 0 0
5 Total profit before tax -112213000 -207755000
6 Tax expense
7 Current tax 0 0
8 Deferred tax -6962000 -5845000
9 Total tax expenses -6962000 -5845000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -105251000 -201910000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -105251000 -201910000
17 Other comprehensive income net of taxes 1144000 1144000
18 Total Comprehensive Income for the period -104107000 -200766000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 92190000 92190000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -11.42 -21.9
Diluted earnings (loss) per share from continuing operations -11.42 -21.9
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -11.42 -21.9
Diluted earnings (loss) per share from continuing and discontinued operations -11.42 -21.9
24 Debt equity ratio 0.0273 0.0273
25 Debt service coverage ratio -0.0024 -0.0024
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 254588000
Capital work-in-progress
Investment property
Goodwill 0
Other intangible assets 0
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 2063000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 8069000
Total non-current financial assets 8069000
Deferred tax assets (net) 0
Other non-current assets 6743000
Total non-current assets 271463000
2 Current assets
Inventories 499706000
Current financial asset
Current investments 0
Trade receivables, current 132471000
Cash and cash equivalents 3067000
Bank balance other than cash and cash equivalents 3623000
Loans, current 0
Other current financial assets 35071000
Total current financial assets 174232000
Current tax assets (net) 0
Other current assets 0
Total current assets 673938000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 945401000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 92190000
Other equity 54286000
Total equity attributable to owners of parent 146476000
Non controlling interest
Total equity 146476000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 37859000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 37859000
Provisions, non-current 8043000
Deferred tax liabilities (net) 9134000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 55036000
Current liabilities
Current financial liabilities
Borrowings, current 362612000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 62199000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 273922000
Total Trade payable 336121000
Other current financial liabilities 522000
Total current financial liabilities 699255000
Other current liabilities 40256000
Provisions, current 4378000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 743889000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 798925000
Total equity and liabilites 945401000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 1529000 1529000
Total Amount of items that will not be reclassified to profit and loss 1529000 1529000
2 Income tax relating to items that will not be reclassified to profit or loss 385000 385000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 1144000 1144000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -207755000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 39776000
Adjustments for decrease (increase) in inventories -5769000
Adjustments for decrease (increase) in trade receivables, current 183568000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 31847000
Adjustments for decrease (increase) in other non-current assets -5069000
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 6712000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 13586000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 16958000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 25016000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 1240000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current -3559000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -42000
Adjustments for dividend income 0
Adjustments for interest income -19869000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -247000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 323886000
Net cash flows from (used in) operations 116131000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 1223000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 114908000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 10451000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received -19868000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1500000
Net cash flows from (used in) investing activities -31819000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -36185000
Repayments of borrowings 6338000
Payments of lease liabilities 0
Dividends paid 0
Interest paid 39776000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -82299000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 790000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 790000
Cash and cash equivalents cash flow statement at beginning of period 2278000
Cash and cash equivalents cash flow statement at end of period 3068000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 N V S R & Associates LLP Yes 30-Jun-2026


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 VINEET LABORATORIES LIMITED WOHLER LABORATORIES PVT LIMITED Entity in which Directors of the Listed Company are interested Any other transaction payments 50000 approved 50000 -65000 -15000
2 VINEET LABORATORIES LIMITED WOHLER LABORATORIES PVT LIMITED Entity in which Directors of the Listed Company are interested Any other transaction receipts 1000 approved 1000 -65000 -15000
3 VINEET LABORATORIES LIMITED VINEET LIFE SCIENCES PRIVATE LIMITED Entity in which Directors of the Listed Company are interested Purchase of goods or services 107242000 approved 107242000 180179000 91051000
4 VINEET LABORATORIES LIMITED VINEET LIFE SCIENCES PRIVATE LIMITED Entity in which Directors of the Listed Company are interested Sale of goods or services 71814000 approved 71814000 180179000 91051000
5 VINEET LABORATORIES LIMITED VINEET LIFE SCIENCES PRIVATE LIMITED Entity in which Directors of the Listed Company are interested Any other transaction payments 28613000 approved 28613000 180179000 91051000
6 VINEET LABORATORIES LIMITED VINEET LIFE SCIENCES PRIVATE LIMITED Entity in which Directors of the Listed Company are interested Any other transaction receipts 82313000 approved 82313000 180179000 91051000
7 VINEET LABORATORIES LIMITED ORGANO METALICS PRIVATED LIMITED Entity in which Directors of the Listed Company are interested Purchase of goods or services 147549000 approved 147549000 -24304000 69705000
8 VINEET LABORATORIES LIMITED ORGANO METALICS PRIVATED LIMITED Entity in which Directors of the Listed Company are interested Sale of goods or services 79006000 approved 79006000 -24304000 69705000
9 VINEET LABORATORIES LIMITED ORGANO METALICS PRIVATED LIMITED Entity in which Directors of the Listed Company are interested Any other transaction payments 24900000 approved 24900000 -24304000 69705000
10 VINEET LABORATORIES LIMITED ORGANO METALICS PRIVATED LIMITED Entity in which Directors of the Listed Company are interested Any other transaction Receipts 1758000 approved 1758000 -24304000 69705000
11 VINEET LABORATORIES LIMITED Gaddam VENKATA RAMANA MANAGING DIRECTOR of Listed Company Remuneration 2550000 approved 2550000 850000 2975000
12 VINEET LABORATORIES LIMITED SATYANARAYANA RAJU BHUPATHIRAJU EXECUTIVE DIRECTOR & CFO of Listed Company Remuneration 1950000 approved 1950000 650000 2275000
13 VINEET LABORATORIES LIMITED BHASKAR REDDY KARNA INDEPENDENT DIRECTOR of Listed Company Any other transaction sitting fees 25000 approved 25000 0 0
14 VINEET LABORATORIES LIMITED YERUKALAPUDI HARI PRIYA INDEPENDENT DIRECTOR of Listed Company Any other transaction sitting fees 50000 approved 50000 0 0
15 VINEET LABORATORIES LIMITED DILIP VISHNU ACHREKAR INDEPENDENT DIRECTOR of Listed Company Any other transaction sitting fees 50000 approved 50000 0 0
16 VINEET LABORATORIES LIMITED Alluri RANGA RAJU NON-EXECUTIVE DIRECTOR of Listed Company Any other transaction sitting fees 50000 approved 50000 0 0
Total value of transaction during the reporting period 547921000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt